NCT06269484: An ongoing trial by AstraZeneca
This trial is ongoing. It must report results 4 days, 1 hour ago.
Full data
| Full entry on ClinicalTrials.gov | NCT06269484 |
|---|---|
| Title | A Multicentre, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Combination Compared to Zibotentan Monotherapy, Zibotentan/Dapagliflozin and Zibotentan Monotherapy Compared to Placebo in Participants With Cirrhosis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 15, 2024 |
| Completion date | Dec. 11, 2024 |
| Required reporting date | Dec. 11, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |